Market Tracker

11/21 6:05pm ET

Rosetta Genomics Ltd (NASDAQ:ROSG)

2.53
Data as of Nov 21
 +0.15 / +6.30%
Today’s Change
2.25
Today|||52-Week Range
6.69
-13.36%
Year-to-Date
No recent news for Rosetta Genomics Ltd.

Today’s Trading

Previous close2.38
Today’s open2.34
Day’s range2.33 - 2.67
Volume136,927
Average volume (3 months)73,064
Market cap$29.6M
Dividend yield--
Data as of 4:00pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+42.98%
Earnings growth (this year)+8.33%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+101.49%
P/E ratio--
Price/Sales69.17
Price/Book1.12

Competitors

 Today’s
change
Today’s
% change
--BioPharmX Corp-0.50-16.67%
CRMDCorMedix Inc-0.05-3.25%
CMXCCell MedX Corp+0.01+0.69%
NNABNanoantibiotics Inc-0.02-7.14%
Data as of 4:01pm ET, 11/21/2014

Financials

Last reporting dateNovember 7, 2013
EPS forecast (this quarter)-$0.35
Annual revenue (last year)$405.0K
Annual profit (last year)-$12.9M
Net profit margin-3,251.85%

Profile

Sector
Health Technology
Industry
Biotechnology
President, CEO &
Head-Investor Relations
Kenneth A. Berlin
Chief Financial Officer
Ron Kalfus
Corporate headquarters
Rehovot, --

Forecasts